Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07452211) titled 'First in Man Study of Pulsed Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 1 Patient' on Feb. 28.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Hangzhou Dinova EP Technology Co., Ltd

Condition: Paroxysmal Atrial Fibrillation (PAF)

Intervention: Device: CardioPulsesTM pulsed field ablation system

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: December 18, 2020

Target Sample Size: 10

Countries of Recruitment: China

To k...